Brain abscesses are common among HIV-infected immunocompromised patients. Encephalitis caused by Toxoplasma gondii infection has to be presumed, on which treatment is initiated. The authors report an unusual case of a brain abscess caused by Staphylococcus aureus in an HIV-infected patient exposed to enfuvirtide, for which this empirical strategy failed.
Luft BJ, Hafner R., Korzun AH, et al. Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. N Engl J Med. 1993;329:995-1000.
2.
Antinori A., Larussa D., Cingolani A., et al. Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy. Clin Infect Dis. 2004 ;39:1681-1691.
3.
Prasad KN, Mishra AM, Gupta D., Husain N., Husain M., Gupta RKAnalysis of microbial etiology and mortality in patients with brain abscess . J Infect. 2006;53:221-227.
4.
Osenbach RK, Loftus CMDiagnosis and management of brain abscess. Neurosurg Clin N Am. 1998;3:403-420.
5.
Dureux J., Voiriot P., Auque J., Gerard A., May T., Canton P.Bases of antibiotherapy in neuromeningeal infections. Neurochirurgie . 1998;34:72-82.
6.
Lazzarin A., Clotet B., Cooper D., et al. Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia. N Engl J Med. 2003;348:2186-2195.
7.
Lalezari JP, Henry K., O'Hearn M., et al. Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America. N Engl J Med. 2003;348:2175-2185.
8.
Trottier B., Walmsley S., Reynes J., et al. Safety of enfuvirtide in combination with an optimized background of antiretrovirals in treatment-experienced HIV-1-infected adults over 48 weeks. J Acquir Immune Defic Syndr. 2005;40:413-421.
9.
Portilla J., Boix V., Merino E., Reus S., Segui JM, Lopez-Azkarreta I.Vertebral osteomyelitis and epidural abscess in a patient receiving enfuvirtide . Eur J Clin Microbiol Infect Dis. 2004;23:580-581.
